BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN, L2
Market cap: $2.1B (2/11/2026)
Price: $21.64
Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
Other Events
Shareholders Approve the Proposed Acquisition
Announces Completion of Enrollment in Phase 3 REVITALYZ™ Trial in Idiopathic Hypersomnia
Announces Increased Offer to Acquire
Board of Directors Declares Proposal a 'Company Superior Proposal'
Receives Unsolicited Proposal
Q3
Q2
Q1
FY 2024
FY 2023 amended
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Registration of Securities
Effectiveness Notice
Additional Proxy Materials
Definitive Merger Proxy Statement
PRER14A
Statement of Changes in Beneficial Ownership
S-8 POS